Skip to main content
Erschienen in:

01.06.2019 | Case report

90y-dotatate/lutetium-(177lu)-oxodotreotide

Chest pain and haematological toxicity : 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kunikowska J, et al. Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: Which is a better therapy option?. European Journal of Nuclear Medicine and Molecular Imaging 38: 1788-1797, No. 10, Oct 2011. Available from: URL: http://doi.org/10.1007/s00259-011-1833-x - Poland Kunikowska J, et al. Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: Which is a better therapy option?. European Journal of Nuclear Medicine and Molecular Imaging 38: 1788-1797, No. 10, Oct 2011. Available from: URL: http://​doi.​org/​10.​1007/​s00259-011-1833-x - Poland
Metadaten
Titel
90y-dotatate/lutetium-(177lu)-oxodotreotide
Chest pain and haematological toxicity : 3 case reports
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63560-4